Provision of Hypertension and Lipids Management Services

  • NHS Norfolk & Waveney Integrated Care Board

F14: Notice for changes or additional information

Notice identifier: 2025/S 000-080578

Procurement identifier (OCID): ocds-h6vhtk-05eb4b

Published 8 December 2025, 12:37pm



Section one: Contracting authority/entity

one.1) Name and addresses

NHS Norfolk & Waveney Integrated Care Board

County Hall, Martineau Ln

Norwich

NR1 2DH

Email

david.bailey1@nhs.net

Country

United Kingdom

Region code

UKH15 - Norwich and East Norfolk

Internet address(es)

Main address

https://www.improvinglivesnw.org.uk/about-us/our-nhs-integrated-care-board-icb/icb-contact/

Buyer's address

https://www.improvinglivesnw.org.uk/about-us/our-nhs-integrated-care-board-icb/icb-contact/


Section two: Object

two.1) Scope of the procurement

two.1.1) Title

Provision of Hypertension and Lipids Management Services

Reference number

NW2025-109

two.1.2) Main CPV code

  • 85100000 - Health services

two.1.3) Type of contract

Services

two.1.4) Short description

NHS Norfolk and Waveney Integrated Care Board is seeking a procure a Hypertension and Lipids Optimisation service. The successful provider staff will be expected to work with the ICB Cardiovascular disease team, the N&W Protect NoW team, and General Practice to improve clinical effectiveness through case finding and management of patients.

NHS Norfolk and Waveney Integrated Care Board is seeking to launch a large-scale CVD Prevention project using a Population Health Management approach to case finding and intervention. The project will focus on hypertension and lipid management, with patients being identified and subsequently risk-stratified using the ICB software.

The ABCDE program aims to improve the care of patients at risk of Cardiovascular events through case finding and improved management of high-risk individuals. This project is considered a system priority to see our population lead healthier, longer lives, whilst simultaneously reducing pressures on the health system through early detection and management.

The successful provider is expected to supply and manage Clinical Prescribers who will liaise with the ICB Protect NoW team, General Practice, and patients. A personalised care approach will be used to support pharmacological and social prescribing for our patient cohort.
Prescribers must be able to initiate relevant medicines.
Prescribers must initiate medicines in line with N&W criteria.

Patients will be identified using the ICB’s population health management software (Eclipse). The ICB Protect NoW Team will contact patients via digital (and print, if necessary) mediums to inform them of their relative risks and changes they can make in their lifestyles and diets and to encourage medication adherence where necessary.

Patients identified as eligible for medication will be consented by Protect NoW and subsequently made available to the provider, and the prescribers are to systematically contact this patient cohort and seek to initiate and / or optimise treatment in line with ICB and national guidance.

The provider will be expected to liaise with the relevant Practice where required on necessary ongoing management and monitoring.


Section six. Complementary information

six.6) Original notice reference

Notice number: 2025/S 000-078203


Section seven. Changes

seven.1.2) Text to be corrected in the original notice

Section number

II.1.5.1

Instead of
Text

1800000

Read
Text

1200000

Section number

II.2.6.1

Instead of
Text

1800000

Read
Text

1200000

Section number

II.2.7.1

Instead of
Text

36

Read
Text

24

Section number

II.2.4.1

Instead of
Text

NHS Norfolk and Waveney Integrated Care Board is seeking NHS Norfolk and Waveney Integrated Care Board is seeking a procure a Hypertension and Lipids Optimisation service. The successful provider staff will be expected to work with the ICB Cardiovascular disease team, the N&W Protect NoW team, and General Practice to improve clinical effectiveness through case finding and management of patients.This is a 1 year contract with the option to extend for up to an additional 2 years. The 1 year contract value is a a maximum of £600,000. Any additional extensions are estimated to be £600,000 per annum a maximum contract value of £1,800,000 over the full 3 year contract period.To respond please use the messaging function or the optional response template with the Atamis Procurement Portal – Project reference C404511 . Please access via the ‘Live Opportunities’ list on the Atamis e-procurement system at the following link: https://health-family-contract-search.secure.force.com/?searchtype=Projects. You can search for the opportunity by entering the following contract ref C404511.Service Description:NHS Norfolk and Waveney Integrated Care Board is seeking to launch a large-scale CVD Prevention project using a Population Health Management approach to case finding and intervention. The project will focus on hypertension and lipid management, with patients being identified and subsequently risk-stratified using the ICB software.The ABCDE program aims to improve the care of patients at risk of Cardiovascular events through case finding and improved management of high-risk individuals. This project is considered a system priority to see our population lead healthier, longer lives, whilst simultaneously reducing pressures on the health system through early detection and management.The successful provider is expected to supply and manage Clinical Prescribers who will liaise with the ICB Protect NoW team, General Practice, and patients. A personalised care approach will be used to support pharmacological and social prescribing for our patient cohort.Prescribers must be able to initiate relevant medicines.Prescribers must initiate medicines in line with N&W criteria.Patients will be identified using the ICB’s population health management software (Eclipse). The ICB Protect NoW Team will contact patients via digital (and print, if necessary) mediums to inform them of their relative risks and changes they can make in their lifestyles and diets and to encourage medication adherence where necessary.Patients identified as eligible for medication will be consented by Protect NoW and subsequently made available to the provider, and the prescribers are to systematically contact this patient cohort and seek to initiate and / or optimise treatment in line with ICB and national guidance.The provider will be expected to liaise with the relevant Practice where required on necessary ongoing management and monitoring.

Read
Text

NHS Norfolk and Waveney Integrated Care Board is seeking NHS Norfolk and Waveney Integrated Care Board is seeking a procure a Hypertension and Lipids Optimisation service. The successful provider staff will be expected to work with the ICB Cardiovascular disease team, the N&W Protect NoW team, and General Practice to improve clinical effectiveness through case finding and management of patients.This is a 1 year contract with the option to extend for up to an additional 1 years. The 1 year contract value is a a maximum of £600,000. Any additional extensions are estimated to be £600,000 per annum a maximum contract value of £1,200,000 over the full 2 year contract period.To respond please use the messaging function or the optional response template with the Atamis Procurement Portal – Project reference C404511 . Please access via the ‘Live Opportunities’ list on the Atamis e-procurement system at the following link: https://health-family-contract-search.secure.force.com/?searchtype=Projects. You can search for the opportunity by entering the following contract ref C404511.Service Description:NHS Norfolk and Waveney Integrated Care Board is seeking to launch a large-scale CVD Prevention project using a Population Health Management approach to case finding and intervention. The project will focus on hypertension and lipid management, with patients being identified and subsequently risk-stratified using the ICB software.The ABCDE program aims to improve the care of patients at risk of Cardiovascular events through case finding and improved management of high-risk individuals. This project is considered a system priority to see our population lead healthier, longer lives, whilst simultaneously reducing pressures on the health system through early detection and management.The successful provider is expected to supply and manage Clinical Prescribers who will liaise with the ICB Protect NoW team, General Practice, and patients. A personalised care approach will be used to support pharmacological and social prescribing for our patient cohort.Prescribers must be able to initiate relevant medicines.Prescribers must initiate medicines in line with N&W criteria.Patients will be identified using the ICB’s population health management software (Eclipse). The ICB Protect NoW Team will contact patients via digital (and print, if necessary) mediums to inform them of their relative risks and changes they can make in their lifestyles and diets and to encourage medication adherence where necessary.Patients identified as eligible for medication will be consented by Protect NoW and subsequently made available to the provider, and the prescribers are to systematically contact this patient cohort and seek to initiate and / or optimise treatment in line with ICB and national guidance.The provider will be expected to liaise with the relevant Practice where required on necessary ongoing management and monitoring.

Section number

II.2.11.2

Instead of
Text

This is a 1 year contract with the option to extend for up to an additional 2 years. The 1 year contract value is a a maximum of £600,000. Any additional extensions are estimated to be £600,000 per annum a maximum contract value of £1,800,000 over the full 3 year contract period.

Read
Text

This is a 1 year contract with the option to extend for up to an additional 1 year. The 1 year contract value is a a maximum of £600,000. Any additional extensions are estimated to be £600,000 per annum a maximum contract value of £1,200,000 over the full 2 year contract period.